journey path light sunshine stairs climb reach
Pharma

Outlook wins FDA appeal after formal dispute proceedings

After a formal dispute resolution process, the FDA has decided that Outlook's eye drug candidate Lytenava has shown evidence of effectiveness.
Zoey Becker May 27, 2026 8:26am
graphic image of China flags overlapping with US flags
Favicon Fierce Biotech

Will COINS Act kill China biotech licensing boom?

May 26, 2026 3:50pm
Eliminating KRAS Why targeted protein degraders could redefinewhatspossible in cancer

Eliminating KRAS: How degraders could redefine cancer care

Brought to you by ASTELLAS
Food and Drug Administration

Regulatory tracker: Braftovi nets colorectal cancer wins abroad

May 26, 2026 11:08am
Real-World Evidence in the AI Era What You Can Unlock Depends on What You Build On

RWE in the AI Era: What You Unlock Depends on What You Build On

Brought to you by Flatiron Health
cancer target detection radiopharma radio

Lantheus considers potential $7B Curium buyout proposal: report

May 26, 2026 10:38am
More News

Gilead's once-rejected hepatitis D med wins FDA nod

May 26, 2026 9:49am

Niowave starts building $75M plant to boost radioisotope supply

May 26, 2026 8:35am

AbbVie trims Allergan workforce by 85

May 22, 2026 12:12pm

EU regulator recommends AZ's Etcamah, Novo's Wegovy pill

May 22, 2026 11:58am